Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2 1Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Lymphoma 7Lymphoma, Large B-Cell, Diffuse 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, Non-Hodgkin 3Lymphoma, Follicular 3Leukemia 3Lymphoma, Large-Cell, Anaplastic 2Sezary Syndrome 1Respiratory Tract Diseases 1Rare Diseases 1Prostatic Neoplasms 1Nausea 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, T-Cell 1Lymphoma, Mantle-Cell 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Biphenotypic, Acute 1Immunoblastic Lymphadenopathy 1Hormone Refractory Prostate Cancer 1Hemangioma 1Esophageal Stenosis Acquired 1Dendritic Cell Sarcoma, Interdigitating 1COVID-19 1Ataxia Telangiectasia 1Ataxia 1

Interventions

Whole-Body Irradiation 6Peripheral Blood Stem Cell Transplantation 6fludarabine phosphate 5Etoposide 5Cyclosporine 4Mycophenolic Acid 3Methotrexate 3Melphalan 3Cyclophosphamide 3Antilymphocyte Serum 3pegaspargase 2Methylprednisolone 2Cytarabine 2Carmustine 2Busulfan 2thymoglobulin 1plerixafor 1denileukin diftitox 1Vincristine 1Thiotepa 1Salvia hispanica seed extract 1Radiotherapy 1Psychiatric Rehabilitation 1Prednisone 1Positron-Emission Tomography 1Oxycodone 1Ondansetron 1O(6)-benzylguanine 1Morphine 1Methadone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Lymphoma, Extranodal NK-T-Cell × Prednisone × Clear all
NCT00513188 2016-12-15

Combination Chemotherapy and Denileukin Diftitox in Treating Patients With Newly Diagnosed T-Cell Non-Hodgkin Lymphoma

University of Miami

Phase NA Withdrawn
DermatologicLymphoid

Immunoblastic Lymphadenopathy, Lymphoma, Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Extranodal NK-T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡